Institutional & Family Asset Management »

Miragen Therapeutics shares owned by Institutional & Family Asset Management

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Institutional & Family Asset Management from 13F filings

Historical chart of Institutional & Family Asset Management investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Institutional & Family Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Institutional & Family Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $234 18 13.00
2024-03-31 $315 18 17.50
2023-12-31 $392 18 21.78
2023-09-30 $275 18 15.33
2023-06-30 $238 10 23.80
2023-03-31 $254 10 25.40

More positions owned by Institutional & Family Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Listed Fd Tr Core Alt Fd (CCOR)
Vanguard Whitehall Fds High Div Yld (VYM)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p500 Etf (IVV)
Spdr Gold Tr Gold Shs (GLD)
Apple (AAPL)
Plains All Amern Pipeline L Unit Ltd Partn (PAA)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr Msci Eafe Etf (EFA)
Ishares Tr U.s. Real Es Etf (IYR)

View all positions for Institutional & Family Asset Management

Top funds holding Miragen Therapeutics

BlackRock
BlackRock
Deep Track Capital
VR Adviser
Fairmount Funds Management
Vanguard Group
Paradigm Biocapital Advisors
Perceptive Advisors
State Street Corporation
Commodore Capital
Novo A/S
Tang Capital Management
Alliancebernstein
Maverick Capital
Driehaus Capital Management

View all funds holding Miragen Therapeutics